Novartis (NVS) - News Mentions

Sign up to add (NVS) to your portfolio and access more historical data.

1 50%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 0 0%
Gilead Sciences
Gilead Sciences
GILD		 0 100%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 1 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 100%
Some 330 jobs hit as Novartis closes Morphosys, WiWo reports
December 19
Novartis shutters MorphoSys sites, lays off staff
December 18
BioAge and Novartis seek drug targets for ageing-related diseases
December 18
Novartis says 330 jobs hit as it closes MorphoSys sites
December 18
Novartis AG (NVS): Among the Oversold Global Stocks to Buy Right Now
December 17
NVS vs. LLY: Which Stock Should Value Investors Buy Now?
December 17
Are Investors Undervaluing Novartis (NVS) Right Now?
December 16
FY2024 EPS Estimates for Novartis Lifted by Zacks Research
December 16
Novartis: Time To Increase
December 12
The Zacks Analyst Blog Mastercard, The Procter & Gamble, Novartis AG, IDT and GSI Technology
December 12
Top Stock Reports for Mastercard, Procter & Gamble & Novartis
December 12
Centiva Capital LP Lowers Stock Position in Novartis AG (NYSE:NVS)
December 12
Monte Rosa Therapeutics Announces Closing of Global License Agreement with Novartis to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders
December 11
Monte Rosa Closes Global License Agreement With Novartis
December 10
Novartis announces results from updated analysis of Phase 3 trial of Kisqali
December 10
Longer-term Novartis Kisqali® NATALEE data show durable reduction in distant recurrence in broad population of patients with early breast cancer
December 10

Month over Month

Est. daily news mentions.

Nov 2024 1
Oct 2024 2
Sep 2024 1
Aug 2024 1
Jul 2024 2

How often is Novartis mentioned in the news?

Novartis was mentioned an estimated 1 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Novartis performing compared to its industry peers?

Novartis underperforms its industry peers when it comes to News Mentions, ranking in the 20th percentile.

Has there been an increase or decrease in news mentions of Novartis in the last month?

Novartis' was mentioned in fewer articles yesterday, compared to the same day last month.

Why is it important to track news mentions for Novartis?

By monitoring mentions in the news for Novartis, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Novartis, ultimately improving their investment strategies.

Sign up and get more insights on Novartis.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact